These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 4589189
1. [Polygraphic evaluation of a new vasoactive drug (nicergoline)]. Baturic P, Cirignotta F. Minerva Cardioangiol; 1973 Oct; 21(10):664-7. PubMed ID: 4589189 [No Abstract] [Full Text] [Related]
2. [Therapeutic action of nicergoline in the treatment of cerebrovascular and peripheral disorders]. Pasotti C, Liverta C, Cacciatori D, Pollini C. Farmaco Prat; 1974 Sep; 29(9):508-19. PubMed ID: 4608968 [No Abstract] [Full Text] [Related]
3. [Effects of nicergoline on hemodynamics and metabolism of the brain in primary arterial hypertension and in arteriosclerosis]. Maiolo AT, Bianchi Porro G, Galli C, Sessa M. Clin Ter; 1972 Aug 15; 62(3):239-52. PubMed ID: 5081153 [No Abstract] [Full Text] [Related]
6. [Clinical use of a new vasoactive drug : nicergoline]. Mellini M. Minerva Med; 1973 May 16; 64(34):1844-53. PubMed ID: 4719381 [No Abstract] [Full Text] [Related]
7. [Cerebral angiodynamic effects of nicotinic acid in man. (Polygraphic and angiographic studies)]. Corsi C, Spinelli P. Rass Neurol Veg; 1967 Dec 31; 21(6):337-52. PubMed ID: 5608551 [No Abstract] [Full Text] [Related]
8. [Serial angiographic evaluation of the effects of various vasoactive drugs on cerebral circulation in man]. Bernini FP, Smaltino F. Acta Neurol (Napoli); 1974 Mar 31; 29(2):170-84. PubMed ID: 4849693 [No Abstract] [Full Text] [Related]
9. [Clinical efficacy of nicergoline in cerebrovascular diseases. Statistical study]. Guardamagna C, Negri S. Minerva Cardioangiol; 1972 Nov 31; 20(11):636-41. PubMed ID: 4566130 [No Abstract] [Full Text] [Related]
10. [Current treatment of cerebrovascular disorder with vasoactive drugs]. Lebiediewa NW. Neurol Neurochir Pol; 1981 Nov 31; 15(4):417-21. PubMed ID: 6895779 [Abstract] [Full Text] [Related]
12. [Action of nicergoline on the cerebral circulatory insufficiency due to arteriosclerosis. Clinical and angioserographic evaluation]. Bernini FP, Muras I, Maglione F, Smaltino F. Farmaco Prat; 1977 Jan 31; 32(1):32-46. PubMed ID: 838039 [No Abstract] [Full Text] [Related]
13. [Effect of antianginal agents on the cerebral circulatory indices in cerebral arteriosclerosis]. Eninia GI, Smeltere ES, Godlevska MA, Logina IP. Klin Med (Mosk); 1985 Sep 31; 63(9):45-8. PubMed ID: 4068626 [No Abstract] [Full Text] [Related]
14. [Use of sermion in cerebral atherosclerosis patients with a history of ischemic stroke]. Tsimenko OA, Sosnov IuD, Kharchenko AP, Gaĭduk IuS. Vrach Delo; 1988 Jul 31; (7):24-7. PubMed ID: 3188456 [No Abstract] [Full Text] [Related]
16. [The dynamics of the cerebral circulation and of brain functional activity in patients with initial atherosclerotic encephalopathy under the influence of a single intravenous administration of sermion]. Mints AIa, Karaban' IN, Litvinenko AA. Farmakol Toksikol; 1991 Jul 31; 54(4):59-62. PubMed ID: 1786832 [Abstract] [Full Text] [Related]
17. [Effect of sulfocamphocaine on the systemic and cerebral hemodynamics of patients with chronic cerebral circulatory failure]. Ishchenko MM, Shkrobot SI. Vrach Delo; 1984 Jul 31; (7):68-70. PubMed ID: 6475025 [No Abstract] [Full Text] [Related]
18. [Cosaldon in the treatment of cerebral arteriosclerosis]. Dzialek E, Orzechowska-Wolczyk M, Zawadzki Z. Wiad Lek; 1975 Sep 15; 28(18):1547-9. PubMed ID: 1163042 [No Abstract] [Full Text] [Related]
20. [Effects of nicotinic acid on cerebral and peripheral blood supply in attacks (rheoencephalographic and oscillographic studies)]. Hadjiev D. Psychiatr Neurol Med Psychol (Leipz); 1965 Aug 15; 17(8):291-6. PubMed ID: 5847589 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]